Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Kebba

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|October 18, 2003
Antiretroviral therapy in sub-Saharan Africa: myth or reality?Anthony Kebba
Nature Immunology|August 23, 2006
An anniversary without celebration?Nesrina Imami, Anthony Kebba, Frances Gotch
AIDS Research and Human Retroviruses|December 19, 2002
Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patientsAnthony Kebba, Diana Atwine, Raymond Mwebaze, et al.
The Journal of Infectious Diseases|April 30, 2004
Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individualsAnthony Kebba, Pontiano Kaleebu, Samantha Rowland, et al.
Pharmacogenomics|March 30, 2007
Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trialsAnthony Kebba, Nesrina Imami, Daniel Bugembe-Lule, et al.
Journal of Leukocyte Biology|April 1, 2005
Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjectsAnthony Kebba, Justin Stebbing, Samantha Rowland, et al.
AIDS Research and Human Retroviruses|March 6, 2004
HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative UgandansAnthony Kebba, Pontiano Kaleebu, Jennifer Serwanga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2003
Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adultsHidehiko Takahashi, Kazunori Oishi, Hiroyuki Yoshimine, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|October 18, 2003
Antiretroviral therapy in sub-Saharan Africa: myth or reality?Anthony Kebba
Nature Immunology|August 23, 2006
An anniversary without celebration?Nesrina Imami, Anthony Kebba, Frances Gotch
AIDS Research and Human Retroviruses|December 19, 2002
Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patientsAnthony Kebba, Diana Atwine, Raymond Mwebaze, et al.
The Journal of Infectious Diseases|April 30, 2004
Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individualsAnthony Kebba, Pontiano Kaleebu, Samantha Rowland, et al.
Pharmacogenomics|March 30, 2007
Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trialsAnthony Kebba, Nesrina Imami, Daniel Bugembe-Lule, et al.
Journal of Leukocyte Biology|April 1, 2005
Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjectsAnthony Kebba, Justin Stebbing, Samantha Rowland, et al.
AIDS Research and Human Retroviruses|March 6, 2004
HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative UgandansAnthony Kebba, Pontiano Kaleebu, Jennifer Serwanga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2003
Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adultsHidehiko Takahashi, Kazunori Oishi, Hiroyuki Yoshimine, et al.
Pageof 1